Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) NEK2 Antibodies:
anti-Rat (Rattus) NEK2 Antibodies:
anti-Human NEK2 Antibodies:
Go to our pre-filtered search.
Human Polyclonal NEK2 Primary Antibody for WB - ABIN392650
Chen, Riley, Zheng, Chen, Lee: Phosphorylation of the mitotic regulator protein Hec1 by Nek2 kinase is essential for faithful chromosome segregation. in The Journal of biological chemistry 2002
Show all 6 references for ABIN392650
Human Polyclonal NEK2 Primary Antibody for EIA, WB - ABIN360538
Eto, Elliott, Prickett, Brautigan: Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation. in The Journal of biological chemistry 2002
Show all 5 references for ABIN360538
Human Polyclonal NEK2 Primary Antibody for IF (p), IHC (p) - ABIN713921
Zhong, Guan, Dong, Yang, Liu, Zhang: Examining Nek2 as a better proliferation marker in non-small cell lung cancer prognosis. in Tumour biology 2014
Show all 3 references for ABIN713921
Human Monoclonal NEK2 Primary Antibody for ICFC - ABIN2666354
Hames, Fry: Alternative splice variants of the human centrosome kinase Nek2 exhibit distinct patterns of expression in mitosis. in The Biochemical journal 2001
Show all 3 references for ABIN2666354
Human Monoclonal NEK2 Primary Antibody for IHC (f), IF - ABIN968053
Fry, Schultz, Bartek, Nigg: Substrate specificity and cell cycle regulation of the Nek2 protein kinase, a potential human homolog of the mitotic regulator NIMA of Aspergillus nidulans. in The Journal of biological chemistry 1995
Show all 2 references for ABIN968053
Human Polyclonal NEK2 Primary Antibody for EIA, WB - ABIN360537
Cantrell: Phosphoinositide 3-kinase signalling pathways. in Journal of cell science 2001
Human Polyclonal NEK2 Primary Antibody for WB - ABIN392649
Blume-Jensen, Hunter: Oncogenic kinase signalling. in Nature 2001
Cep85 is a bona fide Nek2A-binding partner that surrounds the proximal ends of centrioles where it cooperates with PP1gamma (also known as PPP1CC (show PPP1CC Antibodies)) to antagonize Nek2A
The results suggest that overexpression of NEK2 has the potential to serve as a biomarker for PCa (show ENPP1 Antibodies) prognosis.
Nek2 transgenic mice develop spontaneous germinal centers and exhibit an enhanced T cell dependent immune response our data demonstrates a novel role for Nek2 in regulating B cell development and the immune response
these data indicate that Nek2 has a pivotal role in breast cancer growth at primary and secondary sites, and thus may be an attractive and novel therapeutic target for this disease.
CIP2A (show KIAA1524 Antibodies) strongly interacts with NEK2 during G2/M phase, thereby enhancing NEK2 kinase activity to facilitate centrosome separation in a PP1 (show PPP1CC Antibodies)- and PP2A (show PPP2R2B Antibodies)-independent manner.
Nek2 and its substrate, centrobin/Nip2, are required for proper meiotic spindle formation of the mouse oocytes
Data show that NEK2 was identified as a tumor-associated antigen.
Nek2 may be a mitotic regulator that is involved in diverse cell cycle events.
Tcp10 promoter-directed expression of the Nek2 gene in mouse meiotic spermatocytes.
The MAPK (show MAPK1 Antibodies) pathway triggers activation of Nek2 during chromosome condensation in mouse spermatocytes.
NEK2 modulates hepatoma cell functions, including growth, drug resistance, metastasis and angiogenesis via downstream genes activation
Alteration of NEK2 protein levels may contribute to invasion and metastasis of hepatocellular carcinoma
the functional roles of NEK2 in cancer development (review)
NEK2 was associated with unfavorable outcomes in HCC (show FAM126A Antibodies) patients.
enhanced NEK2 expression in hepatocellular carcinoma (HCC (show FAM126A Antibodies)) promotes HCC (show FAM126A Antibodies) progression and drug resistance by promoting PP1 (show PPA1 Antibodies)/Akt (show AKT1 Antibodies) and Wnt (show WNT2 Antibodies) pathway activation, which may represent a new therapeutic target for HCC (show FAM126A Antibodies).
Our findings demonstrated that NEK2 could be a valuable carcinogenic factor and a promising therapeutic target for primary liver cancer
Suggest elevated Nek2 protein expression may be an independent risk factor for colon cancer.
Hepatocellular carcinoma patients with high NEK2 expression had significantly poor recurrence-free survival (p=0.042) and early recurrence after hepatectomy.
Kif24 (show KIF24 Antibodies) is a physiological substrate of Nek2, which regulates cilia disassembly through a concerted mechanism involving Kif24 (show KIF24 Antibodies)-mediated microtubule depolymerization.
This gene encodes a serine/threonine-protein kinase that is involved in mitotic regulation. This protein is localized to the centrosome, and undetectable during G1 phase, but accumulates progressively throughout the S phase, reaching maximal levels in late G2 phase. Alternatively spliced transcript variants encoding different isoforms with distinct C-termini have been noted for this gene.
NIMA (never in mitosis gene a)-related kinase 2
, NIMA - related expressed kinase 2
, NIMA-related expressed kinase 2
, NIMA-related kinase 2
, Nek2 kinase
, never in mitosis A-related kinase 2
, nimA-related protein kinase 2
, serine/threonine-protein kinase Nek2
, serine/threonine protein kinase Nek2
, nimA-like protein kinase 1